Low Expression of RGS2 Promotes Poor Prognosis in High-Grade Serous Ovarian Cancer

SIMPLE SUMMARY: Recent advances in molecular medicine have indicated G-protein coupled receptors (GPCRs) as possible therapeutic targets in ovarian cancer. The cellular effects of GPCRs are determined by regulator of G protein signaling (RGS) proteins. Especially RGS2 has currently moved into focus...

Descripción completa

Detalles Bibliográficos
Autores principales: Ihlow, Jana, Monjé, Nanna, Hoffmann, Inga, Bischoff, Philip, Sinn, Bruno Valentin, Schmitt, Wolfgang Daniel, Kunze, Catarina Alisa, Darb-Esfahani, Sylvia, Kulbe, Hagen, Braicu, Elena Ioana, Sehouli, Jalid, Denkert, Carsten, Horst, David, Taube, Eliane Tabea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561967/
https://www.ncbi.nlm.nih.gov/pubmed/36230542
http://dx.doi.org/10.3390/cancers14194620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561967/
https://www.ncbi.nlm.nih.gov/pubmed/36230542
http://dx.doi.org/10.3390/cancers14194620

Ejemplares similares